Maureen Kozlow, PA
Physician Assistant · Hobart, INNPI 1659040020
Payments from drug & device makers
Across 231 payments — averaging $23.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$797
- Johnson & Johnson$572
- E.r. Squibb & Sons, L.L.C.$548
- Boehringer Ingelheim$522
- Esperion Therapeutics, Inc.$354
- Merck$326
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,511100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 41 | $797 |
| Johnson & Johnson | 18 | $572 |
| E.r. Squibb & Sons, L.L.C. | 26 | $548 |
| Boehringer Ingelheim | 24 | $522 |
| Esperion Therapeutics, Inc. | 16 | $354 |
| Merck | 17 | $326 |
| Novartis | 19 | $297 |
| Silk Road Medical, Inc. | 2 | $264 |
| Boston Scientific | 3 | $236 |
| Chiesi USA, Inc. | 9 | $206 |
| Novo Nordisk | 10 | $166 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $165 |
| Genentech USA, Inc. | 1 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| Pfizer | 6 | $117 |
| Abiomed | 1 | $81 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $77 |
| Scpharmaceuticals Inc. | 3 | $68 |
| AstraZeneca | 4 | $65 |
| Tactile Systems Technology Inc | 3 | $62 |
| Abbott | 3 | $60 |
| Bayer | 2 | $53 |
| W. L. Gore & Associates, Inc. | 2 | $37 |
| Heartflow, Inc. | 1 | $34 |
| Lilly USA, LLC | 2 | $32 |
| Lexicon Pharmaceuticals, Inc. | 2 | $28 |
| Elutia, Inc. | 1 | $22 |
| GSK | 1 | $21 |
| Angiodynamics, Inc. | 1 | $15 |
| Medicomp Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,511 in reported general payments places this provider in the 95th percentile of 1,955 physician assistant providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 101 | $99,912 |
| XareltoRivaroxaban | 56 | $78,942 |
| OzempicSemaglutide | 55 | $63,668 |
| EntrestoSacubitril/Valsartan | 53 | $60,779 |
| Repatha SureclickEvolocumab | 51 | $46,798 |
| MounjaroTirzepatide | 28 | $29,710 |
| FarxigaDapagliflozin Propanediol | 35 | $24,663 |
| BrilintaTicagrelor | 20 | $20,654 |
| NexlizetBempedoic Acid/Ezetimibe | 18 | $16,645 |
| JardianceEmpagliflozin | 15 | $13,508 |
| VascepaIcosapent Ethyl | 19 | $8,920 |
| Potassium Chloride | 37 | $3,818 |
| Ranolazine ErRanolazine | 17 | $2,450 |
| Atorvastatin Calcium | 268 | $1,970 |
| Midodrine Hcl | 13 | $1,892 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $117 | $99,912101 claims |
| Johnson & JohnsonXarelto | $572 | $78,94256 claims |
| Novo NordiskOzempic | $166 | $63,66855 claims |
| NovartisEntresto | $297 | $60,77953 claims |
| AstraZenecaFarxiga, Brilinta | $65 | $45,31755 claims |
| Lilly USA, LLCMounjaro | $32 | $29,71028 claims |
| Esperion Therapeutics, Inc.Nexlizet | $354 | $16,64518 claims |
| Boehringer IngelheimJardiance | $522 | $13,50815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,955 physician assistant providers in Indiana.
Other physician assistant in Hobart
- Kristen GumpfCarmel$142K
- Andrew NordIndianapolis$47K
- Qun Ming ZhangIndianapolis$28K
- Lauren HoweMunster$28K
- A FergusonFort Wayne$22K
- Jacquelyn BeemerFort Wayne$21K
- Lindsay YoderIndianapolis$21K
- Eryn GormanClinton$18K
- Audrey HewittBloomington$17K
- Mackenzie LawsonIndianapolis$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.